Previous Article | Next Article ![]()
Clinical Microbiology Reviews, Oct 1996, 469-488, Vol 9, No. 4
LH Hogan, BS Klein and SM Levitz
Human fungal pathogens have become an increasingly important medical
problem with the explosion in the number of immunocompromised patients as a
result of cancer, steroid therapy, chemotherapy, and AIDS. Additionally,
the globalization of travel and expansion of humankind into previously
undisturbed habitats have led to the reemergence of old fungi and new
exposure to previously undescribed fungi. Until recently, relatively little
was known about virulence factors for the medically important fungi. With
the advent of molecular genetics, rapid progress has now been made in
understanding the basis of pathogenicity for organisms such as Aspergillus
species and Cryptococcus neoformans. The twin technologies of genetic
transformation and "knockout" deletion construction allowed for genetic
tests of virulence factors in these organisms. Such knowledge will prove
invaluable for the rational design of antifungal therapies. Putative
virulence factors and attributes are reviewed for Aspergillus species, C.
neoformans, the dimorphic fungal pathogens, and others, with a focus upon a
molecular genetic approach. Candida species are excluded from coverage,
having been the subject of numerous recent reviews. This growing body of
knowledge about fungal pathogens and their virulence factors will
significantly aid efforts to treat the serious diseases they cause.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Virulence factors of medically important fungi
Department of Pediatrics, University of Wisconsin Medical School, USA. lhhogan@facstaff.wisc.edu
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»